Skip to main content
    S

    Savara Inc (SVRA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.46
    -0.18 (-3.77%)

    Market Cap: $1.02B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Savara Inc (SVRA) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Savara (SVRA) to earn -$0.64 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.23M. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 4 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy333.3%
    Buy666.7%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    9

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 3596.0%.

    Fiscal year ending Dec 31, 2026
    -$0.64
    EPS consensus, revenue $2.23M
    Fiscal year ending Dec 31, 2027
    -$0.34
    EPS consensus, revenue $82.42M
    Next report
    Mar 11, 2027
    Estimated

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.64-$0.77 to -$0.596$2.23MN/A7
    Dec 31, 2027-$0.34-$0.56 to -$0.065$82.42M$64.40M to $153.00M8

    Quarterly Estimates

    The EPS consensus is -$0.16 for both quarters below, ending Dec 31, 2026 and Mar 31, 2027.

    EPS range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.16-$0.22 to -$0.1211$1.84MN/A11
    Mar 31, 2027-$0.16-$0.22 to -$0.124$7.37M$3.00M to $18.00M6

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 8 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202614
    Fiscal year ending Dec 31, 202713
    Quarter ending Mar 31, 202711

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.62.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.64-$0.65-$0.65-$0.62-$0.62N/A
    Fiscal year ending Dec 31, 2027-$0.34-$0.37-$0.37-$0.31-$0.31N/A
    Quarter ending Mar 31, 2027-$0.16-$0.16-$0.16-$0.13-$0.13N/A

    Frequently Asked Questions About SVRA

    What is the SVRA stock forecast?

    Consensus analyst estimates put Savara's EPS at -$0.64 for the fiscal year ending Dec 31, 2026, on revenue of $2.23M. The consensus rating from 9 analysts is Buy.

    How do analysts rate SVRA stock?

    Of 9 analysts covering Savara, 3 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SVRA next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.64, with estimates from -$0.77 to -$0.59 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.34, with estimates from -$0.56 to -$0.06 from 5 analysts.

    What revenue do analysts expect from Savara next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.23M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $82.42M, with estimates from $64.40M to $153.00M.

    How many analysts cover SVRA?

    9 analysts rate Savara stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.